| Deutsch |
English |
| Sprachgebrauch |
usage |
| 5-Benzyl-3,6-dioxo-2- piperazinessigsäure |
5-Benzyl-3,6-dioxo-2-piper-azineacetic acid |
| Poly(3-nonyl-1,1-dioxo-1-thiopropan-1,3-diyl)-block-poly(x-oleyl-7-hydroxy-1,5-diiminooctan-1,8-diyl), Mischung mit x = 1 und/oder 5, neutralisiert mit Dodecylbenzolsulfonsäure |
poly(3-nonyl-1,1-dioxo-1-thiopropane-1,3-diyl)-block-poly(x-oleyl-7-hydroxy-1,5-diiminooctane-1,8-diyl), process mixture with x = 1 and/or 5, neutralised with dodecylbenzenesulfonic acid |
| Natrium-4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluol-3-sulfonat |
Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate |
| Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,7′-disulfonat: höchstens 18 % |
disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulfonate: not more than 18 % |
| Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,5′-disulfonat |
Disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,5′-disulfonate |
| β-Alanin, N-(2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calciumsalz (2: 1), (R)-, Verbindung mit 2,5-Dioxo-4-imidazolydinyl harnstoff |
beta.-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2: 1), (R)-, compound with 2,5-dioxo-4-imidazolydinyl urea |
| β-Carotin-4,4′-dion; Canthaxanthin; 4,4′-Dioxo-β-carotin |
β-Carotene-4,4′-dione; canthaxanthin; 4,4′-dioxo-β-carotene |
| 2,6-Dichlor-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2-(3H)-yl)benzacetonitril |
(+)-4-chlorphenyl [2,6-dichloro-4-(2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazin-2-yl)phenyl] acetonitrile |
| Aluminium, Chlor [(2,5-Dioxo-4-imidazolidinyl)harnstoff] tetrahydroxydi- |
Aluminum, chloro[(2,5-dioxo-4-imidazolidinyl)ureato]tetrahydroxydi- |
| Aluminium, [(2,5-Dioxo-4-imidazolidinyl)harnstoff] dihydroxy- |
Aluminum, [(2,5-dioxo-4-imidazolidinyl)ureato]dihydroxy- |
| Gemisch aus: [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemat und |
A mixture of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; |
| 1-Amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsäure, Dinatriumsalz, Reaktionsprodukte mit 2-[[3-[(4,6-Dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, Natriumsalze |
1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts |
| 1,2-Anthracendicarbonsäure, 3,5,6,8-Tetrahydroxy-9,10-dioxo-7-[2-hydroxy-5-(2-acetamidoethyl)phenyl- |
1,2-anthracenedicarboxylic acid, 3,5,6,8-tetrahydroxy-9,10-dioxo-7-[2-hydroxy-5-(2-acetamidoethyl)phenyl- |
| D-Polygalacturonsäure, Verbindung mit (2,5-Dioxo-4-Imidazolydinyl)-Harnstoff |
D-Polygalacturonic acid, compound with (2,5-dioxo-4-imidazolydinyl)-urea |
| Ausgenommen Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,7′-disulfonat: höchstens 1,0 % |
Excluding disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulfonate: not more than 1,0 % |
| Hexandisäure, Polymer mit 1,3-Dihydro-1,3-dioxo-5-isobenzofurancarbonsäure und 2,2-Dimethyl-1,3-propandiol |
Hexanedioic acid, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid and 2,2-dimethyl-1,3-propanediol |
| Indigotin I besteht im Wesentlichen aus einer Mischung von Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,5′-disulfonat, Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,7′-disulfonat und sonstigen Farbstoffen sowie Natriumchlorid und/oder Natriumsulfat als den… |
Indigotine consists essentially of a mixture of disodium 3,3′dioxo-2,2′-bi-indolylidene-5,5′-disulfonate, and disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulfonate and subsidiary colouring matters together with sodium chloride and/or sodium sulfate as the… |
| hloro-1,3-dimethyl-2,6-dioxo-3,6-dihydro-1H-purin-7-(2H)-id (INNCN) |
N-(4-(2S)-2-[bis(carboxymethyl)amino]-3-[(2RS)-2-[bis(carboxymethyl)amino]propyl (carboxymethyl)amino]propyl phenyl) thiocarbamoyl (INNCN) |
| Olean-12-en-29-olsäure, 3-Hydroxy-11-Oxo-, (3β, 20β)-, Verbindung mit (2,5-Dioxo-4-imidazolydinyl)harnstoff (1:1) |
Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta., 20.beta.)-, compound with (2,5-dioxo-4-imidazolydinyl)urea (1: 1) |
| N-Hydroxymethyl-N-[1,3-di(hydroxy-methyl)-2,5-dioxo-imidazolidinyl-4-yl]-TN- hydroxymethyl-harnstoff |
N-(Hydroxymethyl)-N-(dihydroxymethyl-1,3-dioxo-2,5-imidazolidinyl-4)-N'-(hydroxymethyl) urea |
| 2-Naphthalensulfonsäure,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, Natriumsalz |
2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt |
| 7h-Purin-7-Essigsäure, 1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-, Dihydroxymethylsilylester |
7H-purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, dihydroxymethylsilyl ester |
| N-Acetyl-DL-methionin, Verbindung mit (2,5-Dioxo-4-imidazolidin)harnstoff (1:1) |
N-acetyl-DL-methionine, compound with (2,5-dioxo-4-imidazolidine)urea (1: 1) |
| Mononatrium(2R,3R,4S)-5-(3′)10′-dihydro-7′,8′-dimethyl-2′,4′-dioxo-10′-benzo(g)pteridinyl)-2,3,4-trihydroxypentylphosphat; Mononatriumsalz des 5′-Monophosphatesters von Riboflavin |
Monosodium(2R,3R,4S)-5-(3′)10′-dihydro-7′,8′-dimethyl-2′,4′-dioxo-10′-benzo[γ]pteridinyl)-2,3,4-trihydroxypentyl phosphate; monosodium salt of 5′-monophosphate ester of riboflavin |
| (2S)-5-(Benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansäure |
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid |
| Standardsubstanz: Diclazuril II-24: 2,6-Dichlor-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2-(3H)-yl)benzacetonitril, rein, E 771. |
Standard substance: diclazuril II-24: (+)-4-chlorphenyl [2,6-dichloro-4-(2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazin-2-yl) phenyl] acetonitrile with guaranteed purity, E771 |
| N,N'-Bis-(diethyl)-N,N'-bis-(o-chlorbenzyl)-N,N'-(4,5-dioxo-3,6-diaza-octamethylen)-diammonium-Salze (z. B. Ambenonii chloridum) (INN) |
[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts, e. g. ambenonium chloride (INN) |
| 3-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)propan-1-sulfonat (INNCN) |
rac-(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-yl (INNCN) tofesilate (INNRG) |
| :Die Zeile zum Stoff „(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Tetramethrin“ wird durch folgenden Text ersetzt: |
The row relating to the substance ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-tetramethrin’ shall be replaced by the following text |
| 3,3'-(1,3-Dioxo-1,3-digermoxandiyl)dipropionsäure |
3,3'-(1,3-dioxo-1,3-digermoxanediyl) dipropionic acid |
| 3,5-Dioxo-4-propionylcyclohexan-carboxylat |
3,5-dioxo-4-propionylcyclohexanecarboxylic acid |
| 4-(Cyclopropyl-hydroxymethylen)-3,5-dioxo-cyclohexancarbonsäure |
4-(cyclopropyl-hydroxymethylene)-3,5-dioxo- cyclohexanecarboxylic acid |
| Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit 2H-Thieno[3,4-d]Imidazol-4-Pentansäure, Hexahydro-2-Oxo-, [3as-(3aα,4b,6aα)]- |
Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with 2H-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3aalpha,4b,6aalpha)]- |
| Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit Galacturonsäure |
Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with galacturonic acid |
| Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit 4-Aminobenzoesäure (1:1) |
Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with 4-aminobenzoic acid (1: 1) |
| Harnstoff, (2,5-Dioxo-4-imidazolidinyl)- |
Urea, (2,5-dioxo-4-imidazolidinyl)- |
| English |
Deutsch |
| usage |
Sprachgebrauch |
| 5-Benzyl-3,6-dioxo-2-piper-azineacetic acid |
5-Benzyl-3,6-dioxo-2- piperazinessigsäure |
| poly(3-nonyl-1,1-dioxo-1-thiopropane-1,3-diyl)-block-poly(x-oleyl-7-hydroxy-1,5-diiminooctane-1,8-diyl), process mixture with x = 1 and/or 5, neutralised with dodecylbenzenesulfonic acid |
Poly(3-nonyl-1,1-dioxo-1-thiopropan-1,3-diyl)-block-poly(x-oleyl-7-hydroxy-1,5-diiminooctan-1,8-diyl), Mischung mit x = 1 und/oder 5, neutralisiert mit Dodecylbenzolsulfonsäure |
| Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate |
Natrium-4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluol-3-sulfonat |
| disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulfonate: not more than 18 % |
Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,7′-disulfonat: höchstens 18 % |
| Disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,5′-disulfonate |
Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,5′-disulfonat |
| beta.-Alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2: 1), (R)-, compound with 2,5-dioxo-4-imidazolydinyl urea |
β-Alanin, N-(2,4-Dihydroxy-3,3-dimethyl-1-oxobutyl)-, Calciumsalz (2: 1), (R)-, Verbindung mit 2,5-Dioxo-4-imidazolydinyl harnstoff |
| β-Carotene-4,4′-dione; canthaxanthin; 4,4′-dioxo-β-carotene |
β-Carotin-4,4′-dion; Canthaxanthin; 4,4′-Dioxo-β-carotin |
| (+)-4-chlorphenyl [2,6-dichloro-4-(2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazin-2-yl)phenyl] acetonitrile |
2,6-Dichlor-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2-(3H)-yl)benzacetonitril |
| Aluminum, chloro[(2,5-dioxo-4-imidazolidinyl)ureato]tetrahydroxydi- |
Aluminium, Chlor [(2,5-Dioxo-4-imidazolidinyl)harnstoff] tetrahydroxydi- |
| Aluminum, [(2,5-dioxo-4-imidazolidinyl)ureato]dihydroxy- |
Aluminium, [(2,5-Dioxo-4-imidazolidinyl)harnstoff] dihydroxy- |
| A mixture of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; |
Gemisch aus: [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemat und |
| 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts |
1-Amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsäure, Dinatriumsalz, Reaktionsprodukte mit 2-[[3-[(4,6-Dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, Natriumsalze |
| 1,2-anthracenedicarboxylic acid, 3,5,6,8-tetrahydroxy-9,10-dioxo-7-[2-hydroxy-5-(2-acetamidoethyl)phenyl- |
1,2-Anthracendicarbonsäure, 3,5,6,8-Tetrahydroxy-9,10-dioxo-7-[2-hydroxy-5-(2-acetamidoethyl)phenyl- |
| D-Polygalacturonic acid, compound with (2,5-dioxo-4-imidazolydinyl)-urea |
D-Polygalacturonsäure, Verbindung mit (2,5-Dioxo-4-Imidazolydinyl)-Harnstoff |
| Excluding disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulfonate: not more than 1,0 % |
Ausgenommen Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,7′-disulfonat: höchstens 1,0 % |
| Hexanedioic acid, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid and 2,2-dimethyl-1,3-propanediol |
Hexandisäure, Polymer mit 1,3-Dihydro-1,3-dioxo-5-isobenzofurancarbonsäure und 2,2-Dimethyl-1,3-propandiol |
| Indigotine consists essentially of a mixture of disodium 3,3′dioxo-2,2′-bi-indolylidene-5,5′-disulfonate, and disodium 3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulfonate and subsidiary colouring matters together with sodium chloride and/or sodium sulfate as the… |
Indigotin I besteht im Wesentlichen aus einer Mischung von Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,5′-disulfonat, Dinatrium-3,3′-dioxo-2,2′-bi-indolyliden-5,7′-disulfonat und sonstigen Farbstoffen sowie Natriumchlorid und/oder Natriumsulfat als den… |
| Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3.beta., 20.beta.)-, compound with (2,5-dioxo-4-imidazolydinyl)urea (1: 1) |
Olean-12-en-29-olsäure, 3-Hydroxy-11-Oxo-, (3β, 20β)-, Verbindung mit (2,5-Dioxo-4-imidazolydinyl)harnstoff (1:1) |
| N-(Hydroxymethyl)-N-(dihydroxymethyl-1,3-dioxo-2,5-imidazolidinyl-4)-N'-(hydroxymethyl) urea |
N-Hydroxymethyl-N-[1,3-di(hydroxy-methyl)-2,5-dioxo-imidazolidinyl-4-yl]-TN- hydroxymethyl-harnstoff |
| 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt |
2-Naphthalensulfonsäure,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, Natriumsalz |
| 7H-purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, dihydroxymethylsilyl ester |
7h-Purin-7-Essigsäure, 1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-, Dihydroxymethylsilylester |
| N-acetyl-DL-methionine, compound with (2,5-dioxo-4-imidazolidine)urea (1: 1) |
N-Acetyl-DL-methionin, Verbindung mit (2,5-Dioxo-4-imidazolidin)harnstoff (1:1) |
| Monosodium(2R,3R,4S)-5-(3′)10′-dihydro-7′,8′-dimethyl-2′,4′-dioxo-10′-benzo[γ]pteridinyl)-2,3,4-trihydroxypentyl phosphate; monosodium salt of 5′-monophosphate ester of riboflavin |
Mononatrium(2R,3R,4S)-5-(3′)10′-dihydro-7′,8′-dimethyl-2′,4′-dioxo-10′-benzo(g)pteridinyl)-2,3,4-trihydroxypentylphosphat; Mononatriumsalz des 5′-Monophosphatesters von Riboflavin |
| (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid |
(2S)-5-(Benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansäure |
| Standard substance: diclazuril II-24: (+)-4-chlorphenyl [2,6-dichloro-4-(2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazin-2-yl) phenyl] acetonitrile with guaranteed purity, E771 |
Standardsubstanz: Diclazuril II-24: 2,6-Dichlor-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2-(3H)-yl)benzacetonitril, rein, E 771. |
| The row relating to the substance ‘(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-tetramethrin’ shall be replaced by the following text |
:Die Zeile zum Stoff „(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl(1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-Tetramethrin“ wird durch folgenden Text ersetzt: |
| 3,3'-(1,3-dioxo-1,3-digermoxanediyl) dipropionic acid |
3,3'-(1,3-Dioxo-1,3-digermoxandiyl)dipropionsäure |
| 3,5-dioxo-4-propionylcyclohexanecarboxylic acid |
3,5-Dioxo-4-propionylcyclohexan-carboxylat |
| 5-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran |
1-(4-Fluor-5-hydroxymethyl-tetrahydrofuran-2-yl)-1H-pyrimidin-2,4-dion |
| theoclate, 8-chlorotheophyllinate 8-chloro-1,3-dimethyl-2,6-dioxo-3,6-dihydro-1H-purin-7-(2H)-ide (INNCN) |
tert-Butylacetat, t-Butylacetat, tertiäres Butylacetat |
| 4-(cyclopropyl-hydroxymethylene)-3,5-dioxo- cyclohexanecarboxylic acid |
4-(Cyclopropyl-hydroxymethylen)-3,5-dioxo-cyclohexancarbonsäure |
| Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with 2H-thieno[3,4-d]imidazole-4-pentanoic acid, hexahydro-2-oxo-, [3as-(3aalpha,4b,6aalpha)]- |
Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit 2H-Thieno[3,4-d]Imidazol-4-Pentansäure, Hexahydro-2-Oxo-, [3as-(3aα,4b,6aα)]- |
| Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with galacturonic acid |
Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit Galacturonsäure |
| Urea, (2,5-dioxo-4-imidazolydinyl)-, compound with 4-aminobenzoic acid (1: 1) |
Harnstoff, (2,5-Dioxo-4-Imidazolydinyl)-, Verbindung mit 4-Aminobenzoesäure (1:1) |
| Urea, (2,5-dioxo-4-imidazolidinyl)- |
Harnstoff, (2,5-Dioxo-4-imidazolidinyl)- |
